INFORMED.
LIVE

Vivo Bio tech Ltd.

BSE: VIVOBIOT511509ISIN INE380K01017
  • Healthcare
  • Biotechnology

Share price

₹13.88+0.36 (+2.66%)
as of 4 Nov 2026
Vivo Bio tech Ltd. share price, 4 Nov 2025 to 4 Nov 2026: ₹32.25 to ₹13.88 (-57.0%). Low ₹12.70, high ₹33.52. Volume shown below the price.

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high
₹35.76
52W low
₹12.20
Off 52W high
-61.19%
1M return
-7.34%
3M return
-36.04%
6M return
-49.91%
1Y return
-56.96%
20D avg volume
8,717
50 DMA
₹16.05
200 DMA
₹23.08

Key ratios Consolidated

Market cap
₹30.80 Cr
Current price
₹13.88
52W high / low
₹35.76 / ₹12.20
Face value
₹10.00
P/E
-10.78
P/B
0.33
EPS (TTM)
₹-1.29
Book value / share
₹41.98
ROE
—
ROCE
7.20%
Operating margin
—
Net margin
—
Debt / equity
0.72
Net debt
₹65.94 Cr
Interest cover
1.82
Dividend yield
—
Dividend / share (TTM)
—
Payout
—
Cash conversion cycle
122.8 days

Financials

MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24
Income statement
14.2814.2013.5113.1112.5112.2912.2112.0410.13—
0.060.030.140.130.140.150.014.630.01—
14.3414.2313.6513.2412.6512.4412.2216.6710.15—
14.0013.3812.0811.7311.1711.2010.7610.809.92—
-1.000.000.000.000.000.00————
2.862.772.981.111.641.560.830.911.51—
4.734.884.334.083.203.143.223.442.34—
1.241.481.401.471.501.681.842.061.92—
3.532.752.662.572.642.252.252.292.23—
2.641.901.531.522.313.36————
0.340.861.571.511.481.241.465.870.22—
0.00-0.600.000.000.000.000.000.000.00—
0.340.251.571.511.481.241.465.870.22—
0.155.410.320.640.140.180.640.630.06—
0.19-5.161.250.871.341.060.825.230.17—
0.08-2.520.560.450.740.690.553.510.11—
Key metrics
5.114.485.635.555.625.175.5510.224.37—
35.80%31.50%41.70%42.30%44.90%42.10%45.50%84.90%43.10%—
1.30%-36.30%9.30%6.60%10.70%8.60%6.70%43.40%1.70%—
—1.20%—2.20%—2.50%————
14.10%15.50%10.60%8.90%23.50%—————
-85.80%-586.80%52.40%-83.40%688.20%—————
MetricTTMFY26FY25FY24
Income statement
55.1053.3446.67—
0.360.444.80—
55.4653.7851.48—
51.1948.3642.68—
-1.000.000.00—
9.728.494.81—
18.0216.4912.14—
5.595.857.50—
11.5110.639.02—
7.597.278.23—
4.285.418.79—
-0.60-0.600.00—
3.674.818.79—
6.526.521.51—
-2.85-1.717.28—
-1.43-0.824.76—
Key metrics
20.7721.2925.31—
37.70%39.90%54.20%—
-5.17%-3.20%15.60%—
—7.20%14.10%—
12.33%14.30%——
-133.73%-123.50%——
—-2.5111.60—
—-20.431.62—
—0.720.69—
—65.9452.75—
—122.8148.9—
Balance sheet
—178.43143.23—
—28.4241.94—
—1.441.28—
—11.7511.25—
—8.157.79—
——0.76—
—71.8064.38—
—1.960.00—
—30.2327.84—
—67.3854.03—
—20.7719.09—
—46.6134.94—
—93.1677.90—
Cash flow
—34.9311.83—
—-59.35-15.84—
—24.573.90—
—37.440.23—
MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24
Income statement
14.1413.7713.3713.0212.4212.2912.2112.0410.13—
0.060.030.140.130.140.150.014.630.01—
14.2013.8013.5113.1512.5612.4412.2216.6710.15—
13.8613.2211.9311.6411.0411.0810.6910.729.91—
-1.000.000.000.000.000.00————
2.862.772.981.111.631.560.830.911.51—
4.594.724.173.993.073.023.143.362.33—
1.241.481.401.471.501.681.842.061.92—
3.532.752.662.572.642.252.252.292.23—
2.641.901.531.522.313.36————
0.340.581.581.511.521.361.545.950.23—
0.00-0.600.000.000.000.00————
0.34-0.021.581.511.521.361.545.950.23—
0.155.410.320.640.140.180.640.630.06—
0.18-5.441.260.871.371.190.895.310.18—
0.08-2.650.570.450.760.780.603.560.12—
Key metrics
5.114.215.645.555.665.295.6310.304.38—
36.10%30.60%42.20%42.60%45.60%43.00%46.10%85.50%43.20%—
1.30%-39.50%9.40%6.70%11.00%9.70%7.30%44.10%1.80%—
—1.00%—2.30%—2.70%————
13.80%12.00%9.50%8.10%22.60%—————
-86.90%-557.10%41.60%-83.60%661.10%—————
MetricTTMFY26FY25FY24
Income statement
54.3052.5746.67—
0.360.444.80—
54.6653.0151.48—
50.6547.8242.40—
-1.000.000.00—
9.728.494.81—
17.4715.9511.86—
5.595.857.50—
11.5110.639.02—
7.597.278.22—
4.015.199.08—
-0.60-0.600.00—
3.414.589.08—
6.526.521.51—
-3.13-1.947.57—
-1.55-0.934.95—
Key metrics
20.5121.0625.60—
37.77%40.10%54.90%—
-5.76%-3.70%16.20%—
—7.20%14.60%—
10.91%12.60%——
-135.73%-125.60%——
—-1.3311.60—
—-18.611.56—
—0.690.66—
—62.6250.59—
—125.7148.6—
Balance sheet
—174.86141.29—
—28.1743.31—
—1.301.21—
—11.7511.21—
—8.157.79—
——0.76—
—68.4461.02—
—1.800.00—
—30.0727.84—
—63.9251.80—
—20.7719.09—
—43.1532.71—
—93.2278.19—
Cash flow
—36.1111.83—
—-59.35-15.84—
—23.343.90—
—37.440.23—

Compounded growth

Standalone

Sales CAGR 3Y
—
Sales CAGR 5Y
—
Profit CAGR 3Y
—
Profit CAGR 5Y
—
Sales YoY (TTM)
+10.91%
Profit YoY (TTM)
-135.73%

Consolidated

Sales CAGR 3Y
—
Sales CAGR 5Y
—
Profit CAGR 3Y
—
Profit CAGR 5Y
—
Sales YoY (TTM)
+12.33%
Profit YoY (TTM)
-133.73%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding
22.51%
QuarterSeptember 2026June 2026
Promoter %22.51%30.62%
HolderTypeHoldingPreviousChange
DWIGHT TECHNOLOGIES PRIVATE LIMITEDPublic13.85%8.44%+5.41%
ANTIQUE INFOTECH PRIVATE LIMITEDPublic11.71%11.71%0.00%
MORE AGRISUPPLIES AND SERVICES PRIVATE LIMITEDPublic6.27%3.57%+2.70%
Vira Systems Private LimitedPromoter Group6.06%6.06%0.00%
ELITE CLASS ASSET HOLDINGS LTDPublic5.86%5.86%0.00%
IRAGAVARAPU CONSTRUCTIONS PRIVATE LIMITEDPromoter Group4.51%4.51%0.00%
KOMPELLA VISWANATHPromoter3.38%3.38%0.00%
KOMPELLA RAMAKRISHNA PARAMAHAMSAPromoter Group3.08%3.08%0.00%
IRON AGE INDIA LTDPromoter Group2.70%——
EVERY WEAR IMPORT AND EXPORT PRIVATE LIMITEDPublic1.61%1.61%0.00%
MALLEMKONDA REALITIES PVT LTDPublic1.58%——
LOPA MUDRA KOMPELLAPromoter Group1.50%1.50%0.00%
VEAN SMART INFRA PRIVATE LIMITEDPublic1.32%1.32%0.00%
PINAPALA ANILKUMARPublic1.08%1.08%0.00%
KOMPELLA MODINIPromoter Group1.01%1.01%0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

CompanyMkt cap (₹ Cr)Price (₹)P/EROCESales YoYProfit YoY1Y return
Anthem Biosciences Limited50,022887.4581.4526.80%——+26.33%
Advanced Enzyme Technologies Limited3,121278.7017.3913.60%+10.31% TTM+18.17% TTM-11.17%
Ennature Bio Pharma Limited584261.25—————
CCME GLOBAL LIMITED S16335.93-189.11-1.80%—-124.71% TTM-78.98%
Vivo Bio tech Ltd.3113.88-10.787.20%+12.33% TTM-133.73% TTM-56.96%
Shree Ganesh Biotech (India) Limited S180.44-44.000.80%-77.47% TTM-400.00% TTM-39.73%
GENOMIC VALLEY BIOTECH LIMITED S1755.67-5,567.001.00%-80.30% TTM-110.00% TTM+56.46%

Filings & corporate actions

Recent announcements

Board meetings

  • Board Meeting - Financial Results